State AZ
Clinical Trials in Arizona
Recruiting clinical trials with at least one study location in Arizona. Data updated daily from ClinicalTrials.gov.
Top Conditions in Arizona
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
NCT06721962 Phase 1, Phase 2
Recruiting
Treatment of Moderate to Severe Refractory Crohn's Disease
Condition
Crohns Disease
Enrollment
39 pts
Location
United States
Sponsor
Tr1X, Inc.
NCT05447923 N/A
Recruiting
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved P...
Condition
Colorectal Carcinoma
Enrollment
450 pts
Location
United States
Sponsor
Mayo Clinic
NCT04910269 Phase 3
Recruiting
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
Condition
COVID
Enrollment
820 pts
Location
United States, Argentina, Australia
Sponsor
University of Minnesota
NCT06321302 Phase 2
Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diab...
Condition
Diabetic Retinopathy
Enrollment
178 pts
Location
United States, Germany, Hungary
Sponsor
Boehringer Ingelheim
NCT07018700 Phase 3
Recruiting
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preve...
Condition
Episodic Migraine
Enrollment
990 pts
Location
United States, Austria, Czechia
Sponsor
Merz Therapeutics GmbH
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT04282044 Phase 1
Recruiting
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients...
Condition
Solid Tumor, Adult
Enrollment
60 pts
Location
United States
Sponsor
BioEclipse Therapeutics
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05633667 Phase 2
Recruiting
Study of Novel Treatment Combinations in Patients With Lung Cancer
Condition
Lung Cancer
Enrollment
270 pts
Location
United States, Brazil, Hong Kong
Sponsor
Gilead Sciences
NCT05405595 Phase 1, Phase 2
Recruiting
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic So...
Condition
Advanced/Metastatic Solid Tumors
Enrollment
186 pts
Location
United States, China, South Korea
Sponsor
Adagene Inc
NCT03551392 N/A
Recruiting
Pilot Intervention With Near Infrared Stimulation
Condition
Aging
Enrollment
24 pts
Location
United States
Sponsor
University of Florida
NCT04349436 Phase 1, Phase 2
Recruiting
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ...
Condition
Merkel Cell Carcinoma
Enrollment
90 pts
Location
United States
Sponsor
Replimune Inc.
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT04060030 Phase 2
Recruiting
Treatment of Social and Language Deficits With Leucovorin for Young Children Wit...
Condition
Autism Spectrum Disorder
Enrollment
80 pts
Location
United States
Sponsor
Southwest Autism Research & Re
NCT05691244 Phase 3
Recruiting
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Is...
Condition
Acute Ischemic Stroke
Enrollment
514 pts
Location
United States, Germany, Spain
Sponsor
Pharmazz, Inc.
NCT06637644 N/A
Recruiting
Impella RP Flex with Smart Assist
Condition
Right Ventricular (RV) Dysfunction
Enrollment
200 pts
Location
United States
Sponsor
Abiomed Inc.
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT06570798 Phase 2
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune ...
Condition
Systemic Lupus Erythematosus
Enrollment
220 pts
Location
United States, Australia, Belgium
Sponsor
Amgen
NCT06830993 N/A
Recruiting
Physical Activity Prescription Program for Hemodialysis Patients
Condition
Hemodialysis
Enrollment
40 pts
Location
United States
Sponsor
University of Arizona
NCT06333171 Phase 2
Recruiting
4-aminopyridine for Skin Wound Healing
Condition
Wounds
Enrollment
150 pts
Location
United States
Sponsor
John Elfar
NCT07207811 Phase 3
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine...
Condition
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Enrollment
1,280 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT06008093 Phase 3
Recruiting
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combinati...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
280 pts
Location
United States
Sponsor
AstraZeneca
NCT06841354 Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Comb...
Condition
Triple Negative Breast Neoplasms
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06751056 N/A
Recruiting
Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch
Condition
Pruritus
Enrollment
12 pts
Location
United States
Sponsor
Mayo Clinic